SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019856
Filing Date
2022-05-12
Accepted
2022-05-12 16:09:43
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aadi-10q_20220331.htm   iXBRL 10-Q 4417951
2 EX-10.1 aadi-ex101_280.htm EX-10.1 201425
3 EX-21.1 aadi-ex211_172.htm EX-21.1 3008
4 EX-31.1 aadi-ex311_7.htm EX-31.1 22927
5 EX-31.2 aadi-ex312_9.htm EX-31.2 24020
6 EX-32.1 aadi-ex321_12.htm EX-32.1 11676
7 EX-32.2 aadi-ex322_6.htm EX-32.2 12761
  Complete submission text file 0001564590-22-019856.txt   9929037

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA aadi-20220331.xsd EX-101.SCH 50431
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aadi-20220331_cal.xml EX-101.CAL 41535
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aadi-20220331_def.xml EX-101.DEF 150318
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20220331_lab.xml EX-101.LAB 406456
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20220331_pre.xml EX-101.PRE 306933
60 EXTRACTED XBRL INSTANCE DOCUMENT aadi-10q_20220331_htm.xml XML 1110422
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 22917866
SIC: 2834 Pharmaceutical Preparations